Chenguang Biotech Group Co.,Ltd.’s Net Profit Rose 31% in First Half of 2023

Chenguang Biotech Group Co.,Ltd. (晨光生物科技集团股份有限公司) (300138.SZ) reported a net profit of 314.9 million yuan in the first half of 2023, up 31% year-on-year.

Meanwhile, the company posted 3.7 billion yuan in revenue, up 13.7% year-on-year.

At the end of the reporting period, it had 7.2 billion yuan in total assets and 3.8 billion yuan in total liabilities, with a liability-to-asset ratio of 52.2%.